Resultados da pesquisa - Rudolf M. Huber

Refinar resultados
  1. 1
    Maximal inspiratory mouth pressures (PIMAX) in healthy subjects—what is the lower limit of normal?

    Maximal inspiratory mouth pressures (PIMAX) in healthy subjects—what is the lower limit of normal? Por Hŭbert Haŭtmann, S. HEFELE, K. Schotten, Rudolf M. Huber

    Publicado em 2000
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  2. 2
    Place of cryotherapy, brachytherapy and photodynamic therapy in therapeutic bronchoscopy of lung cancers

    Place of cryotherapy, brachytherapy and photodynamic therapy in therapeutic bronchoscopy of lung cancers Por J.-M. Vergnon, Rudolf M. Huber, K. Moghissi

    Publicado em 2006
    Obter o texto integral Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  3. 3
    High Frequency Jet Ventilation in Interventional Fiberoptic Bronchoscopy

    High Frequency Jet Ventilation in Interventional Fiberoptic Bronchoscopy Por Hŭbert Haŭtmann, Fernando Gamarra, Markus O. Henke, Stephanie Diehm, Rudolf M. Huber

    Publicado em 2000
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  4. 4
    Interactions among Lung Cancer Cells, Fibroblasts, and Macrophages in 3D Co-Cultures and the Impact on MMP-1 and VEGF Expression

    Interactions among Lung Cancer Cells, Fibroblasts, and Macrophages in 3D Co-Cultures and the Impact on MMP-1 and VEGF Expression Por Xiaoqing Liu, Rosemarie Kiefl, Claudia C. Roskopf, Fei Tian, Rudolf M. Huber

    Publicado em 2016
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  5. 5
    Interdisciplinary multimodality management of stage III nonsmall cell lung cancer

    Interdisciplinary multimodality management of stage III nonsmall cell lung cancer Por Rudolf M. Huber, Dirk De Ruysscher, Hans Hoffmann, Simone Reu, Amanda Tufman

    Publicado em 2019
    Obter o texto integral Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:
  6. 6
    Effect of growth hormone (hGH) replacement therapy on physical work capacity and cardiac and pulmonary function in patients with hGH deficiency acquired in adulthood.

    Effect of growth hormone (hGH) replacement therapy on physical work capacity and cardiac and pulmonary function in patients with hGH deficiency acquired in adulthood. Por Ralf Nass, Rudolf M. Huber, V. Klauss, Otto Müller, Jochen Schopohl, Christian J. Strasburger

    Publicado em 1995
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  7. 7
    Simultaneous Chemoradiotherapy Compared With Radiotherapy Alone After Induction Chemotherapy in Inoperable Stage IIIA or IIIB Non–Small-Cell Lung Cancer: Study CTRT99/97 by the Bronchial Carcinoma Therapy Group

    Simultaneous Chemoradiotherapy Compared With Radiotherapy Alone After Induction Chemotherapy in Inoperable Stage IIIA or IIIB Non–Small-Cell Lung Cancer: Study CTRT99/97 by the Bro... Por Rudolf M. Huber, Michael Flentje, Michael Schmidt, Barbara Pöllinger, H. Gosse, Jochen Willner, Kurt Ulm

    Publicado em 2006
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  8. 8
    Chronic progressive HIV-1 infection is associated with elevated levels of myeloid-derived suppressor cells

    Chronic progressive HIV-1 infection is associated with elevated levels of myeloid-derived suppressor cells Por Thomas Vollbrecht, Renate Stirner, Amanda Tufman, Julia Roider, Rudolf M. Huber, Johannes R. Bogner, Andreas Lechner, Carole Bourquin, Rika Draenert

    Publicado em 2012
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  9. 9
    Paradigm shifts in lung cancer as defined in the new IASLC/ATS/ERS lung adenocarcinoma classification

    Paradigm shifts in lung cancer as defined in the new IASLC/ATS/ERS lung adenocarcinoma classification Por William D. Travis, E. Brambilla, Paul Van Schil, Giorgio V. Scagliotti, Rudolf M. Huber, Sculier Jp, Johan Vansteenkiste, Andrew G. Nicholson

    Publicado em 2011
    Obter o texto integral Obter o texto integral
    Editorial
    Adic. favoritos
    Na minha lista:
  10. 10
    Uric acid, lung function, physical capacity and exacerbation frequency in patients with COPD: a multi-dimensional approach

    Uric acid, lung function, physical capacity and exacerbation frequency in patients with COPD: a multi-dimensional approach Por Kathrin Kahnert, Peter Alter, Tobias Welte, Rudolf M. Huber, Jürgen Behr, Frank Biertz, Henrik Watz, Robert Bals, Claus Vogelmeier, Rudolf A. Jörres

    Publicado em 2018
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  11. 11
    The European Respiratory Society and European Society of Thoracic Surgeons clinical guidelines for evaluating fitness for radical treatment (surgery and chemoradiotherapy) in patients with lung cancer

    The European Respiratory Society and European Society of Thoracic Surgeons clinical guidelines for evaluating fitness for radical treatment (surgery and chemoradiotherapy) in patie... Por Alessandro Brunelli, Anne Charloux, Chris T. Bolliger, Gaetano Rocco, Jean‐Paul Sculier, Gonzálo Varela, Marc Licker, Mark K. Ferguson, Corinne Faivre‐Finn, Rudolf M. Huber

    Publicado em 2009
    Obter o texto integral Obter o texto integral
    Editorial
    Adic. favoritos
    Na minha lista:
  12. 12
    Efficacy of the Irreversible ErbB Family Blocker Afatinib in Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI)–Pretreated Non–Small-Cell Lung Cancer Patients with Brain Metastases or Leptomeningeal Disease

    Efficacy of the Irreversible ErbB Family Blocker Afatinib in Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI)–Pretreated Non–Small-Cell Lung Cancer Patients... Por Petra Hoffknecht, Amanda Tufman, Thomas Wehler, Theo Pelzer, Rainer Wiewrodt, Martin Schütz, Monika Serke, Jan Stöhlmacher-Williams, Angela Märten, Rudolf M. Huber, N Dickgreber

    Publicado em 2014
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  13. 13
    Guideline adherence of tumor board recommendations in lung cancer and transfer into clinical practice

    Guideline adherence of tumor board recommendations in lung cancer and transfer into clinical practice Por Julia Walter, Caroline Moeller, Blerina Resuli, Diego Kauffmann‐Guerrero, Farkhad Manapov, Julien Dinkel, Jens Neumann, Julia Kovács, Christian Schneider, Rudolf M. Huber, Amanda Tufman

    Publicado em 2023
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  14. 14
    Reference Values of Impulse Oscillometric Lung Function Indices in Adults of Advanced Age

    Reference Values of Impulse Oscillometric Lung Function Indices in Adults of Advanced Age Por Holger Schulz, Claudia Flexeder, Jürgen Behr, Margit Heier, Rolf Holle, Rudolf M. Huber, Rudolf A. Jörres, Dennis Nowak, Annette Peters, H.‐Erich Wichmann, Joachim Heinrich, Stefan Karrasch

    Publicado em 2013
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  15. 15
    Systematic Analysis of Self-Reported Comorbidities in Large Cohort Studies – A Novel Stepwise Approach by Evaluation of Medication

    Systematic Analysis of Self-Reported Comorbidities in Large Cohort Studies – A Novel Stepwise Approach by Evaluation of Medication Por Tanja Lucke, Ronald Herrera, Margarethe Wacker, Rolf Holle, Frank Biertz, Dennis Nowak, Rudolf M. Huber, Sandra Söhler, Claus Vogelmeier, Joachim H. Ficker, Harald Mückter, Rudolf A. Jörres

    Publicado em 2016
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  16. 16
    Characteristics and treatment of new-onset arthritis after checkpoint inhibitor therapy

    Characteristics and treatment of new-onset arthritis after checkpoint inhibitor therapy Por Jan Leipe, Lisa Christ, Andreas Arnoldi, Erik Mille, Frank Berger, Markus V. Heppt, Ilana Goldscheider, Diego Kauffmann‐Guerrero, Rudolf M. Huber, Claudia Dechant, Carola Berking, Hendrik Schulze‐Koops, Alla Skapenko

    Publicado em 2018
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  17. 17
    Screening for Lung Cancer in Individuals Who Never Smoked: An International Association for the Study of Lung Cancer Early Detection and Screening Committee Report

    Screening for Lung Cancer in Individuals Who Never Smoked: An International Association for the Study of Lung Cancer Early Detection and Screening Committee Report Por Anna Kerpel-Fronius, Martin C. Tammemägi, Milena Čavić, Claudia I. Henschke, Long Jiang, Ella A. Kazerooni, Choon‐Taek Lee, Luigi Ventura, Dawei Yang, Stephen Lam, Rudolf M. Huber, Dawei Yang, Javier J. Zulueta, Lucía Viola, Anant Mohan, Choon‐Taek Lee, Milena Čavić, Heidi Schmidt, Ella A. Kazerooni, Ricardo Sales dos Santos, Anna Kerpel-Fronius, Claudia I. Henschke, Luigi Ventura, Long Jiang, Gabriella Sozzi, Martin C. Tammemägi, Stephen Lam, Rudolf M. Huber

    Publicado em 2021
    Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  18. 18
    Interleukin-22 Is Frequently Expressed in Small- and Large-Cell Lung Cancer and Promotes Growth in Chemotherapy-Resistant Cancer Cells

    Interleukin-22 Is Frequently Expressed in Small- and Large-Cell Lung Cancer and Promotes Growth in Chemotherapy-Resistant Cancer Cells Por Sebastian Kobold, Stefanie Völk, Till S. Clauditz, Natascha Jennifer Küpper, Sarah Minner, Amanda Tufman, P Düwell, Michael Lindner, Ina Koch, Simon Heidegger, Simon Rothenfußer, Max Schnurr, Rudolf M. Huber, Waldemar Wilczak, Stefan Endres

    Publicado em 2013
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  19. 19
    Topotecan/Cisplatin Compared with Cisplatin/Etoposide as First-Line Treatment for Patients with Extensive Disease Small-Cell Lung Cancer: Final Results of a Randomized Phase III Trial

    Topotecan/Cisplatin Compared with Cisplatin/Etoposide as First-Line Treatment for Patients with Extensive Disease Small-Cell Lung Cancer: Final Results of a Randomized Phase III Tr... Por Thomas H. Fink, Rudolf M. Huber, David F. Heigener, Corrina Eschbach, Cornelius F. Waller, E.U. Steinhauer, J. Christian Virchow, Frank Eberhardt, H Schweisfurth, Michael Schroeder, T. H. Ittel, Simone Hummler, Norbert Banik, Thomas Bogenrieder, Thomas Acker, M. Wolf

    Publicado em 2012
    Obter o texto integral Obter o texto integral
    Artigo
    Adic. favoritos
    Na minha lista:
  20. 20
    Heat Shock Protein 70 (Hsp70) Peptide Activated Natural Killer (NK) Cells for the Treatment of Patients with Non-Small Cell Lung Cancer (NSCLC) after Radiochemotherapy (RCTx) – From Preclinical Studies to a Clinical Phase II Trial

    Heat Shock Protein 70 (Hsp70) Peptide Activated Natural Killer (NK) Cells for the Treatment of Patients with Non-Small Cell Lung Cancer (NSCLC) after Radiochemotherapy (RCTx) – Fro... Por Hanno M. Specht, Norbert Ahrens, Christiane Blankenstein, Thomas Duell, Rainer Fietkau, Udo S. Gaipl, Christine Günther, Sophie Günther, Gregor Habl, Hubert Hautmann, Matthias Hautmann, Rudolf M. Huber, M. Molls, Robert Offner, Claus Rödel, Franz Rödel, Martin Schütz, Stephanie E. Combs, Gabriele Multhoff

    Publicado em 2015
    Obter o texto integral Obter o texto integral
    Revisão
    Adic. favoritos
    Na minha lista:

Ferramentas de pesquisa: